Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Management of Cardiac Arrhythmias in Post-PCI Patients B. GORENEK Introduction Percutaneous coronary interventions (PCI) have been the fastest growing major invasive procedure in the past decade. Accompanying the obvious benefit, there are certain risks, including cardiac arrhythmias. A variety of arrhythmias and conduction disturbances can occur during PCI. In general, lethal ventricular arrhythmias, including serious ventricular tachycardia (VT) and ventricular fibrillation (VF), have been reported to occur in 1.5–4.4% of the patients undergoing coronary angioplasty. The frequency of these arrhythmias after primary PCI was analysed in data on 3065 patients from Primary Angioplastic in Myocardial Infarction (PAMI) trials [1]. Ventricular arrhythmias occurred in 133 patients (4.3%). Smoking, lack of preprocedural beta-blockers, shorter time from symptom onset to arrival in emergency room initial thrombolysis in myocardial infarction (TIMI) flow grade 0, and right coronary artery-related infarct were variables independently associated with a risk of serious ventricular arrhythmias. These patients had higher rates of complications including cardiopulmonary resuscitation and intubation in the catheterisation laboratory, but had similar frequencies of major adverse cardiac events in hospital and at 1 year. These arrhythmias may be the result of excessive catheter manipulation, intracoronary dye injection, new ischaemic events, or reperfusion injury. Role of Dye Injection and Intracoronary Solutions Various contrast media have been developed for use in coronary angiography and PCI. These contrast media may be divided into ionic contrast media Cardiology Department, Osmangazi University, Eskisehir,Turkey 232 B. Gorenek of high osmolarity, those of low osmolarity, and non-ionic contrast materials. The risk of ventricular arrhythmia from intracoronary dye is greatest with the injection of ionic contrast agents into the right coronary artery, particularly in the setting of prolonged injection or a damped pressure tracing. VF may occur if dye is allowed to remain static in the coronary tree. The incidence of VF during PCI can be significantly decreased by using lowosmolarity non-ionic contrast media lacking calcium-binding additives. However, in some reports, contrary to the current belief in the overall safety of low-osmolarity ionic contrast agents compared with other agents in diagnostic coronary angiography procedures, such agents are associated with an increased risk of sustained ventricular arrhythmias [2]. VF is a serious complication during induction of hypothermia for surgical purposes [3]. In a study published 2 years ago, six patients were found to have VF during intracoronary saline, heparin, contrast medium, or nitrate delivery [4]. These medications did not warm up to body temperature. Immediate intracoronary flush would result in local hypothermia. Thus, to decrease the risk of VF, warmed-up fluid and warmed-up iso-osmolar nonionic contrast agents must be preferred, especially in patients undergoing PCI on the right coronary artery. Management of Ventricular Premature Beats The first period of ventricular premature beats, which usually heralds malignant arrhythmias during acute coronary occlusion, develops after a quiescent period of 1.5–2.5 min and reaches a peak at 5 min. Both re-entrant and non-re-entrant mechanisms contribute to the development of premature beats and malignant ventricular arrhythmias during the early phase of myocardial ischaemia. Complex premature ventricular contractions and occasional non-sustained ventricular tachycardia are seen after 2–3% of apparently uncomplicated angioplasty procedures. These arrhythmias usually abate over 12–36 h and do not, in general, require treatment. However, hypokalaemia and hypomagnesaemia should be ruled out because potassium and magnesium may be depleted by diuretic-induced diuresis and may need to be replaced [5]. Arrhythmias Related to Ischaemia Acute myocardial ischaemia often results in malignant arrhythmias owing to both the direct effects of ischaemia and the resultant haemodynamic compromise during PCI. Some of the most refractory ventricular ectopy is seen Management of Cardiac Arrhythmias in Post-PCI Patients 233 in the setting of profound transmural ischaemia or early myocardial infarction. Venticular fibrillation due to acute ischaemia is a not infrequent complication of PCI. As in diagnostic coronary angiography, it is readily treated by defibrillation and death rarely results. There appears to be no relation to the severity of coronary artery disease, and the cause is partially related to the use of contrast agents or post-PCI complications. Arrhythmic Complications and Patient Characteristics Vessel calibre is one of the important factors in the genesis of arrhythmias in PCI. Huang et al. observed that a small calibre of the right coronary artery and associated ST segment changes played important roles in the patients who experienced VF during the PCI. They suggested that the cause of acute ischaemia might be the size of the guiding catheter. Most of the catheters they used in patients with VF were 7F, except in two cases where a 6F catheter was used. So, small-size catheters should be preferred especially in high-risk patients [4]. The risk of cardiac arrhythmias in PCI is more pronounced in patients with heart failure. Three years ago, DeGeare et al. investigated the predictive value of Killip classification in patients undergoing primary PCI for acute myocardial infarction. Killip classification predicted the incidence of arrhythmias in those patients. This classification was a predictor of mortality in their study. Killip classification on hospital admission was a simple and useful independent predictor of in-hospital and 6-month mortality in patients with acute myocardial infarction who were undergoing primary PCI [6]. Importance of QT Dispersion and Heart Rate Variability QT dispersion may serve as a measure of variability in ventricular recovery time and may be a means of identifying patients at risk of lethal ventricular arrhythmias and sudden death with coronary artery disease. Ashikaga et al. showed that increased QTc dispersion may predict the risk of lethal ventricular arrhythmias during angioplasty. The fact that successful angioplasty decreased QTc dispersion indicates that part of increased QTc dispersion is related to myocardial ischaemia in patients with coronary artery disease [7]. Thus, in patients with QTc dispersion we should be alert for serious ventricular arrhythmias. Nicorandil may precondition the myocardium and may prevent the occurrence of ventricular arrhythmias after coronary angioplasty by suppressing the increase in QT dispersion [8]. 234 B. Gorenek Abrupt coronary occlusion may cause a wide range of autonomic reactions as evidenced by changes in heart rate, blood pressure, and heart rate variability (HRV). Coronary occlusion-induced increase in HRV seems to have a protective effect against the occurrence of complex ventricular arrhythmias during the early stage of abrupt coronary occlusion, suggesting that vagal activation may modify the outcome of acute coronary events with coronary artery disease [9]. Reperfusion Arrhythmias Reperfusion arrhythmias may be one of the manifestations of reperfusion injury. These arrhythmias are common in patients undergoing PCI, which include accelerated idioventricular rhy thms, VT, and VF. Reperfusion arrhythmias, in addition to their importance as a marker of successful reperfusion, need special attention because haemodynamics may rapidly deteriorate during VT or VF. Intracellular calcium overload is believed to play a critical role in the development of reperfusion arrhythmias. Accumulation of calcium in the cell causes damage to the respiratory chain and decreases ATP production, leading to depletion of mitochondrial energy [10]. The oxygen paradox is closely linked to the calcium overload or calcium paradox, since oxygen mediates the uptake of calcium by mitochondria [11]. Oxygen also leads to cell damage during reperfusion through the formation of oxygen radicals [12]. The role of free radicals in the genesis of reperfusion arrhythmias is uncertain. Free-radical-induced damage occurs in the 10 min after reperfusion [13]. Reduced levels of free radical scavengers have been observed within 3 h of angioplasty in patients with acute myocardial infarction [14]. Some strategies may be helpful for the prevention and treatment of reperfusion arrhythmias, but their beneficial affects are limited. Today we know a little about the effectiveness of antioxidant therapy. The results have largely been mixed and the investigation remains focused at the animal level. Magnesium can be a choice, but there are conflicting data on its benefit. Numerous studies have examined the efficacy of vasodilators as cardioprotective agents in ischaemic reperfusion injury. Intracoronary adenosine and papaverine may be effective as cardioprotective agents. Human studies with papaverine have also demonstrated success in improving angiographically documented TIMI flow grades in epicardial arteries [15]. Calcium channel blockers may block intracellular calcium overload and have positive effects on vascular flow. The effects have been demonstrated during the administration of nifedine and verapamil [16]. Two years ago Yoshida et al. showed that administration of dipyridamole can prevent and terminate reperfusion Management of Cardiac Arrhythmias in Post-PCI Patients 235 arrhythmias such as accelerated idioventricular rhythms and VT. They concluded that cAMP-mediated triggered activity may, at least in part, be responsible for reperfusion arrhythmias [17]. Role of Inhibition of the Renin–Angiotensin–Aldosterone System In the normal heart, locally derived angiotensin II may modulate coronary blood flow, inotropy, and chronotropy [18–21], whereas under pathological conditions the renin–angiotensin–aldosterone system (RAS) may influence ventricular growth and myocardial metabolism, induce ventricular arrhythmias during ischaemia and reperfusion injury, and contribute to post-infarction ventricular remodelling [22]. We also know that bradykinin accumulation is a potent cardioprotective mechanism underlying RAS inhibition in ischaemia and reperfusion injury. A role for RAS in reperfusion arrhythmias was suggested by studies in angiotensin II type 1a receptor knockout mice which, compared to wild-type mice, showed less reperfusion arrhythmia despite a similar infarct size. In addition, administration of a selective angiotensin II type 1 receptor before ischaemia blocked reperfusion arrhythmias [23]. An experimental study showed us that losartan attenuates myocardial ischaemia-induced ventricular arrhythmias and reperfusion injury in hypertension, and may be useful in the treatment of ventricular arrhythmias induced by acute myocardial infarction and attenuation of reperfusion injury [24]. Intracoronary enalaprilat infusion in the infarct-related artery is feasible in the setting of primary angioplasty and is safe and well tolerated [25]. Effective cardiac RAS inhibition can be achieved by low-dose intracoronary enalaprilat, which primarily causes a potentiation of bradykinin [25]. Preconditioning and Arrhythmias The incidence of serious ventricular arrhythmias in the presence of intracoronary thrombus was high in a report [26]. Sudden obstruction of the coronary artery without pre-existing coronary artery narrowing was associated with a higher incidence of VF than was obstruction occurring in association with pre-existing stenoses [26]. The profibrillatory effect of thrombus was not detectable in another report. Experimental studies have suggested that the phenomenon of ischaemic preconditioning may increase the VF threshold [27] and reduce the incidence of ischaemic and reperfusion arrhythmias [28]. The mitochondrial KATP channel seems to be important in prevention of myocardium by preconditioning. A study in dogs suggests that preconditioning may exert an antiarrhythmic effect during ischaemia by 236 B. Gorenek modifying cardiac autonomic receptor mechanisms, which results in an improved parasympathetic balance. A preceding short vessel occlusion– reperfusion cycle increases the electrical stability of ischaemic myocardium, so the repeated coronary artery occlusions during PCI protect against ischaemia-induced ventricular arrhythmias [29]. Benefits of Intra-aortic Balloon Counterpulsation Intra-aortic balloon counterpulsation (IABC) has been used following primary PCI in high risk patients in an attempt to improve outcomes by increasing coronary blood flow reserve, decreasing preload and afterload, and augmenting systemic pressure [30]. In high risk patients prophylactic use of IABC may decrease the incidence of VF, especially in patients with cardiogenic shock [30]. Intra-aortic balloon counterpulsation used before primary PCI provides benefit to patients with cardiogenic shock by reducing the incidence of catheterisation laboratory events, including VT. So, we recommend the use of IABC in patients with cardiogenic shock who are undergoing primary PCI. Supraventricular Arrhythmias and Atrial Fibrillation Supraventricular arrhythmias including atrial fibrillation (AF) may be induced by PCI, but they are not as frequent as ventricular arrhythmias. However, AF especially has prognostic significance in patients treated with PCI. Because the patency of infarct-related artery is better, primary PCI is superior to thrombolytic therapy in restoring sinus rhythm in patients with acute myocardial infarction who have developed AF [31]. Kinjo et al. investigated the prognostic significance of AF and atrial flutter in patients with acute myocardial infarction treated with PCI. In their study, the patients with AF were older, were in higher Killip classes, had higher rates of previous myocardial infarction and previous cerebrovascular accident, had systolic blood pressure of less than 100 mmHg and heart rates of 100 beats/min or more, were less likely to smoke, and had a higher prevalence of multivessel disease and poorer reperfusion of infarct-related artery than those without AF. Atrial fibrillation was a common complication in patients with acute myocardial infarction who are treated with PCI and independently influenced 1-year mortality, they said [32]. Atrial fibrillation during PCI tends to revert spontaneously over a period of minutes to hours, but may require additional therapy if it produces ischaemia or haemodynamic instability. Intravenous beta-blockers (e.g. Management of Cardiac Arrhythmias in Post-PCI Patients 237 esmolol, metoprolol), calcium channel blockers (e.g. verapamil), or digoxin may be given and up-titrated until adequate control of ventricular response is achieved. Electrical cardioversion is rarely required. Conduction Defects and Heart Blocks New conduction defects occur in about 0.9% of the patients undergoing coronary angioplasty [33]. Of these, right bundle branch block was the most common, followed by first-degree atrioventricular block. These defects almost always disappeared without treatment before the time of hospital discharge, but occasionally required the elimination of drugs depressing cardiac activity [5]. When complete heart block develops, atropine is rarely helpful in the setting of inadequate escape and deterioration, but should be given anyway. Coughing may help support the circulation and maintain consciousness while a temporary pacing catheter is inserted. Conclusions Either ventricular or atrial arrhythmias or conduction disturbances can be observed during PCI. Some of them occur as a complication of the procedure, but many of the arrhythmias are related to reperfusion injury. The patient’s characteristics, the type of the procedure, the features of the target vessel and the type of the lesion play an important role in the occurrence of arrhythmias. The majority of the arrhythmias tend to revert spontaneously, but when necessary, special treatment must be given promptly. References 1. 2. 3. 4. Mehta RH, Harjai KJ, Grines L et al (2004) Sustained ventricular tachycardia or fibrillation in the cardiac catheterisation laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. J Am Coll Cardiol 43:1765–1772 Hajj-Ali R, Ezzeddine R, Jadonath R et al (2001) Use of low-osmolar ionic contrast agents increases the risk of sustained ventricular arrhythmias during diagnostic coronary angiography. Am J Cardiol 88 (5A): TCT298 Suppl. Kearns JB, Murnaghan MF (1969) Ventricular fibrillation during hypothermia. J Physiol Lond, 203(1):51P-53P Huang JL, Ting CT, Chen YT, Chen SA (2002) Mechanisms of ventricular fibrillation during coronary angioplasty: increased incidence for the small orifice caliber of the right coronary artery. Int J Cardiol 82:221–228 238 B. Gorenek 5. Ellis SG (1994) Elective coronary angioplasty: technique and complications. In: Topol EJ (ed) Textbook of interventional cardiology. Saunders, Philadelphia, pp 186–206 DeGeare WS, Boura JA, Grines LL et al (2001) Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 87:1035–1038 Ashikaga T, Nishizaki M, Arita M et al (1998) Increased QTc dispersion predicts lethal venticular arrhythmias complicating coronary angioplasty. Am J Cardiol 82:814–816 Kato T, Kamiyama T, Maruyama M et al (2001) Nicorandil, a potent cardioprotective agent, reduces QT dispersion during coronary angioplasty. Am Heart J 141:940–943 Airaksinen KE, Ylitalo A, Nimela MJ et al (1999) Heart rate variability and occurrence of ventricular arrhythmias during balloon occlusion of a major coronary artery. Am J Cardiol 83:1000–1005 Matsuma K, Jeremy RW, Schaper J et al (1998) Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation 97:795–804 Opie LH, Coetzee WA ( 1988) Role of calcium ions in reperfusion arrhythmias: Relevance to pharmacologic intervention. Cardiovasc Drugs Ther 2:623–636 Hearse DJ, Tosak A (1988) Free radicals and calcium. Simultaneous interacting triggers as determinants of vulnerability to reperfusion-induced arrhythmias in the rat heart. J Mol Cell Cardiol 20:213–223 Ambrosio G, Weisfeldt ML, Jacobus WE et al (1987) Evidence for a reversible oxygen mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow. Circulation 75:282–291 Lafont A, Marwick TH, Chisolm GM et al (1996) Decreased free radical scavengers with reperfusion after coronary angioplasty in patients with acute myocardial infarction. Am Heart J 1996 131:219–23 Ishihara M, Sato H, Tateishi H et al (1996) Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine. Am Heart J 132:959–963 Tillmanns H, Neumann FJ, Parekh et al (1990) Pharmacologic effects on coronary microvessels during myocardial ischemia. Eur Heart J 11:B10–B15 Yoshida Y, Hirai M, Yamada T et al (2000) Arrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias. Circulation 101:624–630 Saito K, Gutkind JS, Saaverda JM (1987) Angiotensin II binding sites in the conduction system of rat hearts. Am J Physiol 253:1618–1622 Xiang JZ, Scholkens BA, Ganten D, Unger T (1984) Effects of sympathetic nerve stimulation is attenuated by the converting enzyme inhibitor Hoe 498 in isolated rabbit hearts. Clin Exp Hypertens 6:1853–1857 Xiang JZ, Linz W, Becker H et al (1985) Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Eur J Pharmacol 113:215–223 Rogers TB, Gaa ST, Allen IS (1986) Identification and characterization of functional angiotensin II receptors on cultured heart myocytes. J Pharmacol Exp Ther 236:438–444 Dostal DE, Baker KM (1993) Evidence for a role of an intracardiac renin-angiotensin system in normal and failing hearts. Trends Cardiovasc Med 3:67–74 Harada K, Komuro I, Hayashi D et al (1998) Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. Circulation 97:315–317 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. Management of Cardiac Arrhythmias in Post-PCI Patients 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 239 Lee YM, Peng YY, Ding YA et al (1997) Losartan attenuates myocardial ischemiainduced ventricular arrhythmias and reperfusion injury in spontaneously hypertensive rats. Am J Hypertens 10:852–858 Kurz T, Schafer U, Dendorfer A et al (2001) Effects of intracoronary low dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction. Am J Cardiol 88:1351–1357 Coronel R, Wilms-Schopman FJ, Janse MJ (1997) Profibrillatory effects of intracoronary thrombus in acute regional ischemia of the in situ porcine heart. Circulation 96:3985–3991 Gulker H, Kramer B, Stephan K et al (1977) Changes in ventricular fibrillation threshold during regional short-term coronary occlusion and release. Basic Res Cardiol 72:547–562 Lawson CS, Hearse DJ (1996) Anti-arrhythmic protection by ischemic preconditioning in anesthetised dogs and rats. Cardiovasc Res 31:655–662 Airaksinen KEJ, Huikuri HV (1997) Antiarrhythmic effect of repeated coronary occlusion during balloon angioplasty. J Am Coll Cardiol 29:1035–1038 Brodie BR, Stuckey TD, Hansen C et al (1999) Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol 84:18–23 Gorenek B, Birdane A, Unalir A et al (2000) Restoring sinus rhythm in patients with atrial fibrillation complicating acute myocardial infarction: comparison of outcomes of primary angioplasty and thrombolytic therapy (abstract). Eur J Heart Fail, Suppl 1:32 Kinjo K, Sato H, Sato H et al (2003) Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 92:1150–1154 Bredlau CE, Roubin GS, Leimgruber PP et al 81985) In-hospital mortality in patients undergoing elective coronary angioplasty. Circulation 72:1044–1052